Haining Meng,Junyu Wu,Qiao Huang,Jiwen Ren,Jiawei Huang,Weijun Yuan,Xuekun He,Yuhuan Wang,Congxian Cui,Shengwei Xu,Ruowu Shen. The effects of miR-375 expression in NSCLC via the 14-3-3ζ/ERK/MYC pathway. Oncol Transl Med, 2018, 4: 196-202.
The effects of miR-375 expression in NSCLC via the 14-3-3ζ/ERK/MYC pathway
Received:August 06, 2018  Revised:November 26, 2018
View Full Text  View/Add Comment  Download reader
KeyWord:NSCLC; miR-375; 14-3-3ζ; ERK; MYC
Author NameAffiliationE-mail
Haining Meng Qingdao University 1535891698@qq.com 
Junyu Wu Qingdao University  
Qiao Huang Qingdao University  
Jiwen Ren Qingdao University  
Jiawei Huang Qingdao University  
Weijun Yuan Qingdao University  
Xuekun He Qingdao University  
Yuhuan Wang Qingdao University  
Congxian Cui Affiliated Hospital of Qingdao University  
Shengwei Xu The third people’s hospital of Qingdao  
Ruowu Shen Qingdao University shenruowu@aliyun.com 
Hits: 5953
Download times: 6789
Abstract:
      Objective There are several reports that suggest a significant role played by microRNAs (miRNAs) in cell invasion, metastasis, differentiation, and apoptosis in lung cancers. miR-375 is one such miRNA that has been detected in a variety of tumors, but its specific activity in non-small cell lung cancer (NSCLC) remains unclear. Methods In this study, we regulated the expression of miR-375, to evaluate its influence on the 14-3-3ζ/ ERK/MYC pathway in NSCLC. Results The results of our experiments suggest that miR-375 and 14-3-3ζ are highly expressed in NSCLC, and the over-expression of miR-375 increases the invasive, metastatic, and proliferative ability and decreases the apoptotic ability of NSCLC cells. In addition, protein expression levels of 14-3-3ζ, p-ERK, and MYC increased following the overexpression of miR-375. Conclusion Overall, our findings indicate that miR-375 increases the malignant potential of NSCLC via the 14-3-3ζ/ERK/MYC pathway.
Close